Key result
Plasmapheresis significantly reduced serum triglycerides and resulted in a 96.7% recovery rate in patients with hypertriglyceridemia-induced acute pancreatitis.
Why the study?
Hypertriglyceridemia is the third most common cause of acute pancreatitis, but evidence on the management of hypertriglyceridemia-induced acute pancreatitis is lacking.
Does plasmapheresis reduce plasma triglycerides levels and improve recovery in patients with hypertriglyceridemia-induced acute pancreatitis?
Systematic Review (n=91)
Does plasmapheresis reduce plasma triglycerides levels and improve recovery in patients with hypertriglyceridemia-induced acute pancreatitis?
Plasmapheresis appears to be a safe and effective therapeutic procedure for significantly reducing triglyceride levels and facilitating recovery in patients with hypertriglyceridemia-induced acute pancreatitis.
Supports plasmapheresis in hypertriglyceridemia-induced pancreatitis; confirms efficacy and safety in systematic synthesis.
Background and aims: Hypertriglyceridemia is the third most common cause of acute pancreatitis (AP). However, the evidence on the management of hypertriglyceridemia-induced AP is lacking. We undertook a systematic review of all published case reports and series to evaluate the clinical characteristics of hypertriglyceridemia-induced AP patients in whom plasmapheresis was used, and the effect of plasmapheresis on plasma triglycerides levels and procedure-related safety. Materials and methods: A systematic literature search was performed for case reports and series published between January 1, 1975 and April 30, 2023 in PubMed, Science Direct, Embase and Google Scholar databases using keywords "hypertriglyceridemia" AND "pancreatitis" AND "plasmapheresis" OR "plasma exchange." The inclusion criteria were (1) hypertriglyceridemia-induced AP and (2) use of plasmapheresis to manage AP. Results: Seventy-one studies involving 91 unique patients were included in this meta-summary. Nearly three-fourth had severe AP and one-fifth with recurrent pancreatitis. A previous history of hypertriglyceridemia and diabetes was known in 52.7% of the patients, and alcohol abuse in 17.6%. The majority of the patients were young males, with 15 pregnant females. A median of two sessions with a plasma exchange volume of 3 L significantly reduced serum triglycerides in patients with hypertriglyceridemia. Most (96.7%) of the patients recovered with a median hospital and intensive care unit length of stay (LOS) of 11 and 5 days, respectively. Conclusion: Plasmapheresis is an effective therapeutic procedure that can significantly reduce triglycerides levels in hypertriglyceridemia-induced AP. The procedure is reasonably safe, including in patients with severe AP and pregnancy. Future prospective randomized studies are required to evaluate the impact of plasmapheresis on patient-centered outcomes compared with pharmacological management of AP. How to cite this article: Nasa P, Jain R, Singh O, Juneja D. Plasmapheresis for Hypertriglyceridemia-induced Acute Pancreatitis: A Systematic Review and Meta-summary of Case Reports. Indian J Crit Care Med 2025;29(7):604-611.
No takes yet. Share an insight, caveat, or question.
Prashant Nasa (2025) conducted a systematic review in Hypertriglyceridemia-induced Acute Pancreatitis (n=91). Plasmapheresis was evaluated on Recovery. Plasmapheresis significantly reduced serum triglycerides and resulted in a 96.7% recovery rate in patients with hypertriglyceridemia-induced acute pancreatitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: